Here is the memo in which Pfizer's research chief outlines the company's research priorities.

Pharma giant will stop developing cholesterol drugs and focus on Alzheimer?s, schizophrenia and pain.

Firm gives an early warning about negative results with anemia drug.

Bid turns hostile, target says 'no.'

The tiny pharma pens a deal and furthers a drug in one day.